Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Hector S, Izurieta"'
Autor:
Maria C Rodriguez-Barradas, Vincent C Marconi, Yinong Young-Xu, Gabrielle M Zwain, Hector S Izurieta, Caroline Korves, Ethan I Powell, Jeremy Smith, Abirami Balajee, Mark Holodniy, David O Beenhouwer, Sheldon T Brown
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objective To estimate the effectiveness of messenger RNA (mRNA) booster doses during the period of Delta and Omicron variant dominance.Design We conducted a matched test-negative case–control study to estimate the vaccine effectiveness (VE) of thre
Externí odkaz:
https://doaj.org/article/1513fdbd3a0844e1887cd9e7a5b78612
Autor:
F. Scott Dahlgren, David K. Shay, Hector S. Izurieta, Richard A. Forshee, Michael Wernecke, Yoganand Chillarige, Yun Lu, Jeffrey A. Kelman, Carrie Reed
Publikováno v:
Epidemics, Vol 26, Iss , Pp 23-31 (2019)
Using Medicare claims data on prescriptions of oseltamivir dispensed to people 65 years old and older, we present a descriptive analysis of patterns of influenza activity in the United States for 579 core-based statistical areas (CBSAs) from the 2010
Externí odkaz:
https://doaj.org/article/793440d32107498da5950d1362c32156
Autor:
Gayathri Sridhar, Fang Tian, Richard Forshee, Martin Kulldorff, Nandini Selvam, Andrea Sutherland, Wilson Bryan, Samuel Barone, Lei Xu, Hector S. Izurieta
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 7, Pp 1705-1713 (2017)
To assess the relationship between human papillomavirus (HPV) vaccination and occurrence of optic neuritis (ON) and to evaluate a claims-based algorithm for identification of ON. Females of 9–26 year olds in the HealthCore's Integrated Research Dat
Externí odkaz:
https://doaj.org/article/6e2f6e89e3374da6be36bc561ec73277
Autor:
Alexandra M. Mellis, Adam S. Lauring, H. Keipp Talbot, Huong Q. McLean, Kerry Grace Morrissey, Melissa S. Stockwell, Natalie M. Bowman, Yvonne Maldonado, Katherine D. Ellingson, Suchitra Rao, Jessica E. Biddle, Sheroi Johnson, Constance Ogokeh, Phillip P. Salvatore, Carrie Reed, Sarah E. Smith-Jeffcoat, Jennifer K. Meece, Kayla E. Hanson, Edward A. Belongia, Emily E. Bendall, Julie Gilbert, Vanessa Olivo, Lori S. Merrill, Son H. McLaren, Ellen Sano, Celibell Y. Vargas, Lisa Saiman, Raul A Silverio Francisco, Ayla Bullock, Jessica Lin, Prasanthi Govindarajan, Sarah H. Goodman, Clea C. Sarnquist, Karen Lutrick, Karla I. Ledezma, Ferris A. Ramadan, Kathleen Pryor, Flavia N Miiro, Edwin Asturias, Samuel Dominguez, Daniel Olson, Hector S. Izurieta, James Chappell, Christopher Lindsell, Natasha Halasa, Kimberly Hart, Yuwei Zhu, Jonathan Schmitz, Melissa A. Rolfes, Carlos G. Grijalva
BackgroundThe natural history of SARS-CoV-2 infection and transmission dynamics may have changed as SARS-CoV-2 has evolved and population immunity has shifted.MethodsHousehold contacts, enrolled from two multi-site case-ascertained household transmis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74a9ca129ffd9997f9899690d287c23d
https://doi.org/10.1101/2023.05.18.23290185
https://doi.org/10.1101/2023.05.18.23290185
Autor:
Yun Lu, Arnstein Lindaas, Hector S Izurieta, Myrna Cozen, Mikhail Menis, Xiangyu Shi, Whitney Steele, Michael Wernecke, Yoganand Chillarige, Jeffrey A Kelman, Richard A Forshee
This retrospective study utilized healthcare claims data to investigate the incidence, patient demographics, and concurrent diagnoses associated with long COVID in the U.S. Medicare population. Nearly 194,000 (0.6%) beneficiaries had post-COVID condi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b50d63a7f904815382e06569e292e8bc
https://doi.org/10.1101/2023.03.07.23286107
https://doi.org/10.1101/2023.03.07.23286107
Autor:
Yixin Jiao, Yun Lu, Yue Wu, Hector S. Izurieta, Richard A. Forshee, Michael Wernecke, Yoganand Chillarige, David J. Graham, Jeffrey A. Kelman, Jing Wang, Mikhail Menis
Publikováno v:
The Journal of Infectious Diseases
BackgroundWe evaluated prevaccine pandemic period COVID-19 death risk factors among nursing home (NH) residents.MethodsIn a retrospective cohort study covering Medicare fee-for-service beneficiaries aged ≥65 years residing in US NHs, we estimated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228390a1436da4e66ea62d87acfa9c14
https://doi.org/10.1093/infdis/jiab515
https://doi.org/10.1093/infdis/jiab515
Autor:
Yinong Young-Xu, Gabrielle M Zwain, Hector S Izurieta, Caroline Korves, Ethan I Powell, Jeremy Smith, Abirami Balajee, Mark Holodniy, David O Beenhouwer, Maria C Rodriguez-Barradas, Sheldon T Brown, Vincent C Marconi
Publikováno v:
BMJ open. 12(8)
ObjectiveTo estimate the effectiveness of messenger RNA (mRNA) booster doses during the period of Delta and Omicron variant dominance.DesignWe conducted a matched test-negative case–control study to estimate the vaccine effectiveness (VE) of three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462e24ae7d3d366fb8885ef4cf5d02ad
https://pubmed.ncbi.nlm.nih.gov/35922100
https://pubmed.ncbi.nlm.nih.gov/35922100
Autor:
Heng-Ming Sung, Bradley Lufkin, Hector S. Izurieta, Jeffrey A. Kelman, Michael Wernecke, Kathleen Dooling, Yoganand Chillarige, Paula Ehrlich Agger, Yun Lu, Ruth Link-Gelles, Richard A. Forshee, Thomas MaCurdy, Xiyuan Wu
Publikováno v:
Clinical Infectious Diseases. 73:941-948
BackgroundShingrix (recombinant zoster vaccine) was licensed to prevent herpes zoster, dispensed as 2 doses given 2–6 months apart among adults aged ≥50 years. Clinical trials yielded efficacy of >90% for confirmed herpes zoster, but post-market
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f725afeaf8c5b6f37e547d9b6b8706
https://doi.org/10.1093/cid/ciab125
https://doi.org/10.1093/cid/ciab125
Autor:
David J. Graham, Michael Wernecke, Douglas Pratt, Mao Hu, Jeffrey A. Kelman, Richard A. Forshee, Mikhail Menis, Yue Wu, Hector S. Izurieta, Yun Lu, Yoganand Chillarige, Yixin Jiao
Publikováno v:
The Journal of Infectious Diseases
BackgroundThe current study was performed to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) outcomes among Medicare beneficiaries during the pandemic’s early phase.MethodsIn a retrospective cohort study covering Medicare fee-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830c944855a656a71282d69cc698501e
https://doi.org/10.1093/infdis/jiaa767
https://doi.org/10.1093/infdis/jiaa767
Autor:
Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, Kathryn Ryder, Yinong Young-Xu
ImportancePrevious studies have analyzed effectiveness of booster mRNA Covid-19 vaccination and compared it with 2-dose primary series for both Delta and Omicron variants. Observational studies that estimate effectiveness by comparing outcomes among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b2c89e4616ef196b1d304b1d083ec7
https://doi.org/10.1101/2022.03.17.22272555
https://doi.org/10.1101/2022.03.17.22272555